DOCSLIB.ORG

Acute Poststreptococcal Polymyalgia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acute Poststreptococcal Polymyalgia Ann Rheum Dis: first published as 10.1136/ard.45.1.47 on 1 January 1986. Downloaded from Annals of the Rheumatic Diseases, 1986; 45, 47-49 Acute poststreptococcal polymyalgia NOAM HARATS, HANAN GUR, AND ALAN RUBINOW From the Department of Medicine A, Hadassah University Hospital, POB 12000, Jerusalem, Israel SUMMARY Three patients developed severe incapacitating diffuse pain and tenderness of the skeletal muscles after acute streptococcal infection. There was no evidence of concomitant arthritis, glomerulonephritis, or inflammatory muscle disease in any of the cases. All patients responded promptly to anti-inflammatory therapy. Severe myalgia should be considered an additional complication of immunologically mediated poststreptococcal response. Rheumatic fever, acute poststreptoccal glomeru- (515 x 10O/I). Urinalysis was normal, as were the lonephritis, Schonlein-Henoch purpura, and ery- serum electrolytes, glucose, urea, creatinine levels, thema nodosum are well recognised, immunologi- and liver function tests. The serum albumin concen- cally mediated complications of streptococcal tration was 32 gIl. Muscle enzymes, including disease.1 On the other hand, severe diffuse pain creatine phosphokinase, aldolase, transaminase, and tenderness of skeletal muscles without concom- and lactic dehydrogenase, were all within normal itant arthritis is not a recognised feature of post- levels. Many cultures obtained from the throat, copyright. streptococcal disease. Recently, we encountered sputum, urine, and blood were negative. The three patients who developed incapacitating acute serological tests for hepatitis B antigen, Epstein- myalgia after streptococcal infection. Barr virus, cytomegalovirus, and cold agglutinins, the Weil-Felix reaction, Widal test, and test for Case histories antinuclear antibodies were also negative. The antistreptolysin 0 titre was 1/400 on admission and 1/800 two weeks later. The C-reactive protein was CASE 1 An showed T wave inversion http://ard.bmj.com/ A 13-year-old girl was admitted to our department 5+. electrocardiogram to normal during the because of severe myalgia involving the upper and in leads VI-V3 which reverted lower limbs of three days' duration. Two weeks hospitalisation. A chest radiogram was normal. The was treated with 2-7 g daily and before admission she had had an upper respiratory patient aspirin infection. She also had fever, arthralgia of the small responded dramatically. By the following moming muscle had and a scheduled joints of the hands, and was bedridden because of the pain resolved, was cancelled. She remained pain. She had not received any medication. On electromyography symptomless thereafter on maintenance aspirin admission her temperature was 39°C and she had a on September 28, 2021 by guest. Protected diffuse giant urticarial rash. The throat, lungs, and therapy. abdomen showed no abnormal findings. The heart CASE 2 sounds were normal, and no murmurs were heard. A man was admitted to our department There was severe bilateral tenderness and weakness 24-year-old of the deltoid, biceps, and quadriceps muscles, but because of severe myalgia. Ten days previously he a sore throat associated with fever and was were no of arthritis. had there signs with and for three days. A tests showed an erythrocyte sedi- treated ampicillin aspirin Laboratory week later he developed severe proximal and distal mentation rate (ESR) of 80 mm after one hour (Westergen), haemoglobin 11-1 g/dl (111 g/l) with muscle pain and weakness. On admission he normocytic normochromic indexes, leucocytes 8100/ appeared ill and his temperature was 38-10C. The throat, lungs, abdomen, and skin were normal. mm3 (8-1 x 109/l), and thrombocytes 515 000/mm3 Heart sounds were normal, and no murmurs were heard. The proximal and distal muscles were so Accepted for publication 24 May 1985. tender that he was unable to move because of the Correspondence to Dr Noam Harats, Department of Medicine A, Hadassah University Hospital, POB 12000, Jerusalem 91120, incapacitating pain. There was marked weakness of Israel. the proximal and distal muscles of the upper 47 Ann Rheum Dis: first published as 10.1136/ard.45.1.47 on 1 January 1986. Downloaded from 48 Harats, Gur, Rubinow extremities and moderate weakness of the proximal Serum albumin was 24 g/l and globulin 43 g/l; serum and distal muscles of the lower limbs. proteinelectrophoresisshowedanincreaseofa2globu- Laboratory examinations showed: ESR 85 mm lin (24%). Antinuclear antibodies and rheumatoid after one hour, haemoglobin 16-4 g/dl (164 g/l), factor were not detected, and serological tests for white blood cell count 15 600/mm3 (15-6x 109/1) Epstein-Barr virus, cytomegalovirus, and hepatitis with 70% polymorphonuclears, and thrombocytes B antigen were negative. An antistreptolysin 0 titre 336 000/mm3 (336x 109/l). Urinalysis was normal. was 1/833 and increased to 1/1600 a month later. Serum electrolytes, glucose, liver and kidney func- C-reactive protein was 3+. Numerous cultures tion tests were normal. Repeated determinations of obtained from blood, urine, throat, sputum, and muscle enzymes (creatine phosphokinase, lactic cerebrospinal fluid were negative. A chest radio- dehydrogenase, oxaloacetic transaminase, and aldo- gram showed increased intersitial markings, and a lase) were all normal. Serological tests for hepatitis small pericardial effusion was noted on echocar- B antigen, Epstein-Barr virus, cytomegalovirus, diography. Electrocardiography and electromyogra- cold agglutinins, antinuclear antibodies, and phy were normal. rheumatoid factor were negative. The antistreptoly- The patient was treated with prednisone 40 mg sin 0 titre increased over three weeks from 1/160 to daily. Although the fever declined and the myalgia 1/333, and C-reactive protein was 4+. Serum improved gradually, a residual mild proximal protein electrophoresis showed increased a2 globu- myopathy persisted. She was discharged after a lin (19-5% of total protein) and a diffuse hypergam- month on a tapering prednisone regimen. Three maglobulinaemia. An electrocardiogram and chest weeks after discharge a complete resolution of her roentgenogram were normal. Electromyography of myopathy was observed. the biceps, deltoid, flexor digitalis, quadriceps, and gastrocnemius showed mild myopathic changes Discussion without spontaneous activity. In addition, a mild reduction of recruitment and excess of polyphasic The present report describes three patients whocopyright. activity were noted. A muscle biopsy specimen showed a similar clinical picture of severe myalgia obtained from a tender biceps muscle was normal. and fever after streptococcal upper respiratory tract Aspirin in a dose of 4-8 g/day resulted in a prompt infection. The myalgia was characterised by severe relief of pain, and the tenderness disappeared within incapacitating muscle pain and tenderness affecting a week. the proximal and distal muscles of both upper and lower limbs, without increase of muscle enzymes. CASE 3 There was serological evidence of recent streptococ- Two weeks after an untreated upper respiratory cal infection in all cases and non-specific signs of http://ard.bmj.com/ tract infection a 21-year-old woman complained of inflammation, including a high erythrocyte sedi- acute pain and marked weakness in both legs and mentation rate, positive C-reactive protein, and an arms and swelling of the left calf. On admission she increase of a2 globulin. Complete and rapid resolu- appeared to be acutely ill and her temperature was tion was observed on treatment with salicylates in 39°C. Rales were heard over both lung bases, but two patients and prednisone in one case. the heart and abdomen were normal. The muscles of The clinical picture and the positive serological all four limbs were very tender. The strength of the evidence for recent streptococcal infection suggest on September 28, 2021 by guest. Protected proximal muscles of the upper and lower limbs was a pathogenesis similar to rheumatic fever. Drug markedly decreased and that of the distal muscles allergy is unlikely, since only one patient (case 2) moderately decreased. There were no signs of was treated with ampicillin before admission, and arthritis. the drug was discontinued five days before onset of Laboratory data included: ESR 90 mm after one the disease. The clinical manifestations of rheumatic hour, white blood cell count 19 000/mm3 (19x 109/1), fever have undergone considerable modification in with a marked shift to the left. Haemoglobin was 8*5 recent years, and the application of the Jones gtdl (85 g/l) with mild hypochromia (mean corpuscu- criteria in the adult population is often difficult.' 57 lar haemoglobin 24 pg) and thrombocytes 615 000/ In classical rheumatic fever the presence of arthritis mm3 (615 x 109/l). Urinalysis showed + 1 proteinuria or carditis is necessary in order to make the with few red and white blood cells per high power diagnosis. About 12% of patients with suspected fields but with no casts. Serum electrolytes, glucose, rheumatic fever are described as 'minor streptococ- and liver function tests were normal. The blood urea cal disease'2 which usually includes arthralgia, high nitrogen was 28 mg/dl (10 mmol/l). Muscle enzymes, sedimentationr rate, fever, and sometimes a pro- including transaminase, creatine phosphokinase, longed P-R interval in the electrocardiogram. None lactic dehydrogenase, and aldolase, were normal. of the three patients described herein fulfilled the Ann Rheum Dis: first published as 10.1136/ard.45.1.47 on 1 January
Load more

Recommended publications
  • Aetiology of Fibrositis
    Ann Rheum Dis: first published as 10.1136/ard.6.4.241 on 1 January 1947. Downloaded from AETIOLOGY OF FIBROSITIS: A REVIEW BY MAX VALENTINE From a review of systems of classification of fibrositis (National Mineral Water Hospital, Bath, 1940; Devonshire Royal Hospital, Buxton, 1940; Ministry of Health Report, 1924; Harrogate Royal Bath Hospital Report, 1940; Ray, 1934; Comroe, 1941 ; Patterson, 1938) the one in use at the National Mineral Water Hospital, Bath, is considered most valuable. There are five divisions of fibrositis as follows: (a) intramuscular, (b) periarticular, (c) bursal and tenosynovial, (d) subcutaneous, (e) perineuritic, the latter being divided into (i) brachial (ii) sciatic, etc. Laboratory Tests No biochemical abnormalities have been demonstrated in fibrositis. Mester (1941) claimed a specific test for " rheumatism ", but Copeman and Stewart (1942) did not find it of value and question its rationale. The sedimentation rate is usually normal or may be slightly increased; this is confirmed by Kahlmeter (1928), Sha;ckle (1938), and Dawson and others (1930). Miller copyright. and Gibson (1941) found a slightly increased rate in 52-3% of patients, and Collins and others (1939) found a (usually) moderately increased rate in 35% of cases tested. Case Analyses In an investigation Valentine (1943) found an incidence of fibrositis of 31-4% (60% male) at a Spa hospital. (Cf. Ministry of Health Report, 1922, 30-8%; Buxton Spa Hospital, 1940, 49 5%; Bath Spa Hospital, 1940, 22-3%; Savage, 1941, 52% in the Forces.) Fibrositis was commonest http://ard.bmj.com/ between the ages of40 and 60; this is supported by the SpaHospital Report, Buxton, 1940.
    [Show full text]
  • Inflammatory Back Pain in Patients Treated with Isotretinoin Although 3 NSAID Were Administered, Her Complaints Did Not Improve
    Inflammatory Back Pain in Patients Treated with Isotretinoin Although 3 NSAID were administered, her complaints did not improve. She discontinued isotretinoin in the third month. Over 20 days her com- To the Editor: plaints gradually resolved. Despite the positive effects of isotretinoin on a number of cancers and In the literature, there are reports of different mechanisms and path- severe skin conditions, several disorders of the musculoskeletal system ways indicating that isotretinoin causes immune dysfunction and leads to have been reported in patients who are treated with it. Reactive seronega- arthritis and vasculitis. Because of its detergent-like effects, isotretinoin tive arthritis and sacroiliitis are very rare side effects1,2,3. We describe 4 induces some alterations in the lysosomal membrane structure of the cells, cases of inflammatory back pain without sacroiliitis after a month of and this predisposes to a degeneration process in the synovial cells. It is isotretinoin therapy. We observed that after termination of the isotretinoin thought that isotretinoin treatment may render cells vulnerable to mild trau- therapy, patients’ complaints completely resolved. mas that normally would not cause injury4. Musculoskeletal system side effects reported from isotretinoin treat- Activation of an infection trigger by isotretinoin therapy is complicat- ment include skeletal hyperostosis, calcification of tendons and ligaments, ed5. According to the Naranjo Probability Scale, there is a potential rela- premature epiphyseal closure, decreases in bone mineral density, back tionship between isotretinoin therapy and bilateral sacroiliitis6. It is thought pain, myalgia and arthralgia, transient pain in the chest, arthritis, tendonitis, that patients who are HLA-B27-positive could be more prone to develop- other types of bone abnormalities, elevations of creatine phosphokinase, ing sacroiliitis and back pain after treatment with isotretinoin, or that and rare reports of rhabdomyolysis.
    [Show full text]
  • Clinical Data Mining Reveals Analgesic Effects of Lapatinib in Cancer Patients
    www.nature.com/scientificreports OPEN Clinical data mining reveals analgesic efects of lapatinib in cancer patients Shuo Zhou1,2, Fang Zheng1,2* & Chang‑Guo Zhan1,2* Microsomal prostaglandin E2 synthase 1 (mPGES‑1) is recognized as a promising target for a next generation of anti‑infammatory drugs that are not expected to have the side efects of currently available anti‑infammatory drugs. Lapatinib, an FDA‑approved drug for cancer treatment, has recently been identifed as an mPGES‑1 inhibitor. But the efcacy of lapatinib as an analgesic remains to be evaluated. In the present clinical data mining (CDM) study, we have collected and analyzed all lapatinib‑related clinical data retrieved from clinicaltrials.gov. Our CDM utilized a meta‑analysis protocol, but the clinical data analyzed were not limited to the primary and secondary outcomes of clinical trials, unlike conventional meta‑analyses. All the pain‑related data were used to determine the numbers and odd ratios (ORs) of various forms of pain in cancer patients with lapatinib treatment. The ORs, 95% confdence intervals, and P values for the diferences in pain were calculated and the heterogeneous data across the trials were evaluated. For all forms of pain analyzed, the patients received lapatinib treatment have a reduced occurrence (OR 0.79; CI 0.70–0.89; P = 0.0002 for the overall efect). According to our CDM results, available clinical data for 12,765 patients enrolled in 20 randomized clinical trials indicate that lapatinib therapy is associated with a signifcant reduction in various forms of pain, including musculoskeletal pain, bone pain, headache, arthralgia, and pain in extremity, in cancer patients.
    [Show full text]
  • Polyarthralgia: Joint Pain & Fibromyalgia
    Polyarthralgia: Joint Pain & Fibromyalgia - Disabled World 07/23/2015 Skip to Content Accessibility HOME Disability ▼ Health ▼ Sports ▼ Products Videos ▼ About: Document Information A B C D E F G H I J K L M N O P Q • Author: Ian Langtree R S T U V W Y • Contact: Disabled World ★ Polyarthralgia: Joint Pain & Fibromyalgia • Published: 2009-04-22 (Revised: 2015-06-01) ▶ Health and Disability ▶ Bones & Joints - Conditions • Related Topics • Definition of Polyarthralgia Brief Synopsis: Information and • Cite This Document definition of Polyarthralgia usually used 3 Foods Cause Joint Pains to describe aches and pain affecting five • Add or Read Comments or more joints. medixselect.com • Print Page & Screen Readers The One Thing You Should Eat For Your Joints "Polyarthralgia is more common in Every Morning. -Video ▼ Awareness: Ribbons & Dates women and even more so with increasing age." 1 Trick to Fibromyalgia What is Polyarthralgia? Free Knee Pain Relief Kit • Awareness Ribbon Colors & Meaning Polyarthralgia is defined as aches in the • Awareness Days, Weeks & Months joints, joint pains, arthralgia of multiple Anterior Hip Replacement Today 07-23-2015 is: joints, and multiple joint pain. • World Sjogren's Day - Commemorates the Polyarthritis is the word usually used to describe pain affecting five or more joints, while a birthday of Henrik Sjogren, who first identified patient with 2 to 4 joints involved would be said to have oligoarticular disease. this disease in 1933, while bringing organizations across the world together to raise Polyarthralgia is more common in women and even more so with increasing age. awareness about Sjogren's. Polyarthralgia: Signs and Symptoms The initial symptoms, which usually appear in the third to fifth decade of life, include painless swelling or thickening of the skin of the hands and fingers, pain and stiffness of the joints Adrenal Fatigue (polyarthralgia), often mistaken for rheumatoid arthritis, and paroxysmal blanching and MDs cyanosis (becoming blue) of the fingers induced by exposure to cold (Raynaud syndrome).
    [Show full text]
  • Approach to Polyarthritis for the Primary Care Physician
    24 Osteopathic Family Physician (2018) 24 - 31 Osteopathic Family Physician | Volume 10, No. 5 | September / October, 2018 REVIEW ARTICLE Approach to Polyarthritis for the Primary Care Physician Arielle Freilich, DO, PGY2 & Helaine Larsen, DO Good Samaritan Hospital Medical Center, West Islip, New York KEYWORDS: Complaints of joint pain are commonly seen in clinical practice. Primary care physicians are frequently the frst practitioners to work up these complaints. Polyarthritis can be seen in a multitude of diseases. It Polyarthritis can be a challenging diagnostic process. In this article, we review the approach to diagnosing polyarthritis Synovitis joint pain in the primary care setting. Starting with history and physical, we outline the defning characteristics of various causes of arthralgia. We discuss the use of certain laboratory studies including Joint Pain sedimentation rate, antinuclear antibody, and rheumatoid factor. Aspiration of synovial fuid is often required for diagnosis, and we discuss the interpretation of possible results. Primary care physicians can Rheumatic Disease initiate the evaluation of polyarthralgia, and this article outlines a diagnostic approach. Rheumatology INTRODUCTION PATIENT HISTORY Polyarticular joint pain is a common complaint seen Although laboratory studies can shed much light on a possible diagnosis, a in primary care practices. The diferential diagnosis detailed history and physical examination remain crucial in the evaluation is extensive, thus making the diagnostic process of polyarticular symptoms. The vast diferential for polyarticular pain can difcult. A comprehensive history and physical exam be greatly narrowed using a thorough history. can help point towards the more likely etiology of the complaint. The physician must frst ensure that there are no symptoms pointing towards a more serious Emergencies diagnosis, which may require urgent management or During the initial evaluation, the physician must frst exclude any life- referral.
    [Show full text]
  • Arthritis and Joint Pain
    Fact Sheet News from the IBD Help Center ARTHRITIS AND JOINT PAIN Arthritis, or inflammation (pain with swelling) of the joints, is the most common extraintestinal complication of IBD. It may affect as many as 30% of people with Crohn’s disease or ulcerative colitis. Although arthritis is typically associated with advancing age, in IBD it often strikes younger patients as well. In addition to joint pain, arthritis also causes swelling of the joints and a reduction in flexibility. It is important to point out that people with arthritis may experience arthralgia, but many people with arthralgia may not have arthritis. Types of Arthritis • Peripheral Arthritis. Peripheral arthritis usually affects the large joints of the arms and legs, including the elbows, wrists, knees, and ankles. The discomfort may be “migratory,” moving from one joint to another. If left untreated, the pain may last from a few days to several weeks. Peripheral arthritis tends to be more common among people who have ulcerative colitis or Crohn’s disease of the colon. The level of inflammation in the joints generally mirrors the extent of inflammation in the colon. Although no specific test can make an absolute diagnosis, various diagnostic methods—including analysis of joint fluid, blood tests, and X-rays—are used to rule out other causes of joint pain. Fortunately, IBD-related peripheral arthritis usually does not cause any lasting damage and treatment of the underlying IBD typically results in improvement in the joint discomfort. • Axial Arthritis. Also known as spondylitis or spondyloarthropathy, axial arthritis produces pain and stiffness in the lower spine and sacroiliac joints (at the bottom of the back).
    [Show full text]
  • Employees Calling About RTW Clearance
    1. Employee should do home quarantine for 7 days Employees calling and consult their physician about RTW clearance 2. Employee must call their own manager to call in Community/General Exposure OR sick as per their usual policy IP&C or Supervisor Confirmed Exposure 3. To return to work, employee must be fever-free without antipyretic for 3 days (72 hours) AND 1. Confirm that employee symptoms improveD AND finisheD 7-day home has finished 7-day home quarantine Community/General/ Travel/ quarantine AND fever-free Day Zero= First Day of Symptoms without antipyretics for 3 CDC Level 2/3 Country* COVID Permitted work on the 8th day days (72 hours) AND Exposure Employee must call the WHS hotline back symptoms have improved then for RTW clearance Employees who call-in 2. Employee should wear Community/General/ 4.Fill out RTW form to place employee off-duty with non-CLI surgical face mask during Unknown COVID Symptoms, but still entire shift while at work exposure (any not feeling well: going forward 3. If employee has been off- exposure that is NOT Please remember to stay duty for 8 or more calendar “Infection Prevention home if you don’t feel days, then email and Control (IP&C) well. Healthcare team confirmed) [email protected] Personnel must not work with doctor’s note simply sick. Follow usual steps stating that they sought for take sick day and care/treatment for COVID- contact their manager. Note: loss of smell/taste alone does If there are NO like symptoms ANY 4.Employee should update NOT constitute CLI per WHS No RTW form needed for symptoms following their manager COVID-19 Symptoms: guidelines Employees with NO non-CLI exposure or travel, 5.
    [Show full text]
  • Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes
    Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes Type 2 Diabetes ranges from predominantly insulin resistant with relative insulin deficiency to predominantly an insulin secretory defect with insulin resistance, American Diabetes Association, 2010. (ICD 9 code 250.0) Prevalence • 23.6 million Americans have diabetes – 7.8% of U.S. population. Of these, 5.7 million do not know they have the disease. • 1.6 million people ≥20 years of age are diagnosed with diabetes annually. • 90–95% of diabetic patients have Type 2 Diabetes. Manifestations Clinical of untreated diabetes • High blood glucose level • Excessive thirst • Frequent urination • Weight loss • Fatigue Oral • Increased risk of dental caries due to salivary hypofunction • Accelerated tooth eruption with increasing age • Gingivitis with high risk of periodontal disease (poor control increases risk) • Salivary gland dysfunction leading to xerostomia • Impaired or delayed wound healing • Taste dysfunction • Oral candidiasis • Higher incidence of lichen planus Other Potential Disorders/Concerns • Ketoacidosis, kidney failure, gastroparesis, diabetic neuropathy and retinopathy • Poor circulation, increased occurrence of infections, and coronary heart disease Management Medication The list of medications below are intended to serve only as a guide to facilitate the dental professional’s understanding of medications that can be used for Type 2 Diabetes. Medical protocols can vary for individuals with Type 2 Diabetes from few to multiple medications. ACTION TYPE BRAND NAME/GENERIC SIDE EFFECTS Enhance insulin Sulfonylureas Glipizide (Glucotrol) Angioedema secretion Glyburide (DiaBeta, Fluconazoles may increase the Glynase, Micronase) hypoglycemic effect of glipizide Glimepiride (Amaryl) and glyburide. Tolazamide (Tolinase, Corticosteroids may produce Diabinese, Orinase) hyperglycemia. Floxin and other fluoroquinolones may increase the hypoglycemic effect of sulfonylureas.
    [Show full text]
  • Treatment of Taxane Acute Pain Syndrome (TAPS) in Cancer Patients Receiving Taxane-Based Chemotherapy—A Systematic Review
    Support Care Cancer (2016) 24:1583–1594 DOI 10.1007/s00520-015-2941-0 ORIGINAL ARTICLE Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review Ricardo Fernandes1 & Sasha Mazzarello2 & Habeeb Majeed3 & Stephanie Smith 2 & Risa Shorr4 & Brian Hutton5 & Mohammed FK Ibrahim1 & Carmel Jacobs1 & Michael Ong1 & Mark Clemons1,2,6 Received: 21 May 2015 /Accepted: 3 September 2015 /Published online: 19 September 2015 # Springer-Verlag Berlin Heidelberg 2015 Abstract randomized open-label trials 76 patients), and one was a ret- Background Taxane acute pain syndrome (TAPS) is charac- rospective study (10 patients). The agents investigated includ- terized by myalgias and arthralgias starting 1–3 days and last- ed gabapentin, amifostine, glutathione, and glutamine. Study ing 5–7 days after taxane-based chemotherapy. Despite nega- sizes ranged from 10 to 185 patients. Given the heterogeneity tively impacting patient’s quality of life, little is known about of study designs, a narrative synthesis of results was per- the optimal TAPS management. A systematic review of treat- formed. Neither glutathione (QoL, p = 0.30, no 95 % CI re- ment strategies for TAPS across all tumor sites was performed. ported) nor glutamine (mean improvement in average pain Methods Embase, Ovid MEDLINE(R), and the Cochrane was 0.8 in both treatment arms, p = 0.84, no 95 % CI reported) Central Register of Controlled Trials were searched from were superior to placebo. Response to amifostine (pain re- 1946 to October 2014 for trials reporting the effectiveness of sponse) and gabapentin (reduction in taxane-induced arthral- different treatments of TAPS in cancer patients receiving gias and myalgias) was 36 % (95 % CI, 16–61 %) and 90 % taxane-based chemotherapy.
    [Show full text]
  • Therapeutic Optimization of Aromatase Inhibitor–Associated Arthralgia
    Review Therapeutic optimization of aromatase inhibitor–associated arthralgia: etiology, onset, resolution, and symptom management in early breast cancer Cheryl Jones, MD,1 James Gilmore, PharmD,1 Mansoor Saleh, MD,1 Bruce Feinberg, DO,1 Michelle Kissner, RPh, PharmD,2 and Stacey J. Simmons, MD2 1Georgia Cancer Specialists, Macon, GA; 2Pfizer Inc., New York, NY Third-generation aromatase inhibitors (AIs) used in the treatment of hormone-responsive breast cancer are associated with arthralgia, which is the most common reason for treatment discontinuation. This review characterizes the observed arthralgia and describes its variable definitions in key clinical trials; its typical onset and duration; symptom management strategies; and symptom resolution. The symptomatic manifestations of AI-associated arthralgia are highly variable, with typical onset occurring 2-6 months after treatment initiation. Aromatase inhibitor-associated arthralgia is most often bilateral and symmetrical, involving hands and wrists. Other common locations include knees, hips, lower back, shoulders, and feet. To improve standardization of care as well as patient quality of life, we propose a diagnostic algorithm for the management of patients who receive AIs and who develop arthralgia or worsening symptoms from preexisting joint pain. We conclude that although arthralgia is often associated with AI therapy, prompt diagnosis and management of musculoskeletal symptoms may ensure continued AI treatment and improve quality of life. he use of third-generation aromatase in-
    [Show full text]
  • Chronic Pelvic Pain & Pelvic Floor Myalgia Updated
    Welcome to the chronic pelvic pain and pelvic floor myalgia lecture. My name is Dr. Maria Giroux. I am an Obstetrics and Gynecology resident interested in urogynecology. This lecture was created with Dr. Rashmi Bhargava and Dr. Huse Kamencic, who are gynecologists, and Suzanne Funk, a pelvic floor physiotherapist in Regina, Saskatchewan, Canada. We designed a multidisciplinary training program for teaching the assessment of the pelvic floor musculature to identify a possible muscular cause or contribution to chronic pelvic pain and provide early referral for appropriate treatment. We then performed a randomized trial to compare the effectiveness of hands-on vs video-based training methods. The results of this research study will be presented at the AUGS/IUGA Joint Scientific Meeting in Nashville in September 2019. We found both hands-on and video-based training methods are effective. There was no difference in the degree of improvement in assessment scores between the 2 methods. Participants found the training program to be useful for clinical practice. For both versions, we have designed a ”Guide to the Assessment of the Pelvic Floor Musculature,” which are cards with the anatomy of the pelvic floor and step-by step instructions of how to perform the assessment. In this lecture, we present the video-based training program. We have also created a workshop for the hands-on version. For more information about our research and workshop, please visit the website below. This lecture is designed for residents, fellows, general gynecologists,
    [Show full text]
  • Joint Pain and Sjögren’S Syndrome
    Joint Pain and Sjögren’s Syndrome Alan N. Baer, MD, FACP Alan N. Baer, MD, FACP Associate Professor of Medicine Division of Rheumatology Johns Hopkins University School of Medicine Director, Jerome Greene Sjogren's Syndrome Clinic 5200 Eastern Avenue Mason F. Lord Bldg. Center Tower Suite 4100, Room 413 Baltimore MD 21224 Phone (410) 550-1887 Fax (410) 550-6255 In 1930, Henrik Sjögren, a Swedish ophthalmologist, examined a woman with rheumatoid arthritis who had extreme dryness of her eyes and mouth and filamentary keratitis, an eye condition related to her lack of tears (1). He became fascinated by this unusual debilitating condition and subsequently evaluated 18 additional women with the same combination of findings. He described this new syndrome as “keratoconjunctivitis sicca” in his postdoctoral thesis. Thirteen of the 19 women had chronic inflammatory arthritis. We would now classify these 13 women as having secondary Sjögren’s syndrome (SS), occurring in the context of rheumatoid arthritis. However, joint pain constitutes one of the most common symptoms of the primary form of SS, defined as SS occurring in the absence of an underlying rheumatic disease. In a recent survey of SS patients belonging to the French Sjögren’s Syndrome Society (Association Française du Gougerot-Sjögren et des Syndromes Secs), 81% reported significant joint and muscle pain (2). In this article, the joint manifestations of primary SS will be reviewed. A few definitions are needed for the reader. Although the term “arthritis” was originally applied to conditions causing joint inflammation, it now includes disorders in which the joint has become damaged by degenerative, metabolic, or traumatic processes.
    [Show full text]